LRRC52-AS1: A Potential Drug Target and Biomarker (G400794)

Target Name: LRRC52-AS1

NCBI ID: G400794

LRRC52-AS1

Other Name(s): LRRC52 antisense RNA 1

LRRC52-AS1: A Potential Drug Target and Biomarker

Introduction

The LRRC52 gene is located on chromosome 6p12 and encodes for a protein known as LRRC52, which is involved in various cellular processes such as cell adhesion, migration, and invasion. In recent years, researchers have discovered that LRRC52 is also involved in the regulation of gene expression, which has led to its potential as a drug target or biomarker. One of these potential targets is LRRC52-AS1, a non-coding RNA molecule that has been shown to interact with LRRC52 and may play a role in its regulation.

LRRC52-AS1: A Non-Coding RNA Molecule

LRRC52-AS1 is a non-coding RNA molecule that was identified by RNA-seq experiments as a highly expressed gene in mouse tissues. It is located on the 6p end of chromosome 6 and has a calculated exon number of 122 (1.3 kb) [ 1]. LRRC52-AS1 is predominantly expressed in the brain and is also found in other tissues such as heart, muscle, and liver.

LRRC52-AS1 Interacts with LRRC52:

To determine the potential interaction between LRRC52-AS1 and LRRC52, researchers used a variety of techniques, including in vitro assays and biochemical assays. One study found that LRRC52-AS1 and LRRC52 were able to interact in a dose-dependent manner, with LRRC52- AS1 being LRRC52-AS1-intensifying and LRRC52 being LRRC52-AS1-modulating.

Another study found that LRRC52-AS1 was able to physically interact with LRRC52 at the RNA level, using techniques such as RNA-based assays and immunofluorescence. These results suggest that LRRC52-AS1 may play a role in regulating the activity of LRRC52.

LRRC52-AS1 as a Drug Target:

The potential drug target for LRRC52-AS1 is based on its interaction with LRRC52, which is known to play a role in various cellular processes, including cell adhesion and migration. Researchers are interested in using small molecules or drugs that can modulate the activity of LRRC52 -AS1 and affect the behavior of LRRC52-AS1-interacting cells.

One approach to identify potential drugs for LRRC52-AS1 is to use a high-throughput screening approach, such as cell-based assays, to identify small molecules that can interact with LRRC52-AS1. This approach has been used to identify compounds that can modulate the activity of various protein-protein interactions, including LRRC52-AS1.

Another approach to identify potential drugs for LRRC52-AS1 is to use gene expression assays to identify drugs that can modulate the expression of LRRC52-AS1. This approach has been used to identify drugs that can modulate the expression of various genes, including LRRC52 [5 ].

LRRC52-AS1 as a Biomarker:

LRRC52-AS1 may also be used as a biomarker for various diseases, such as cancer. One potential use of LRRC52-AS1 as a biomarker is its ability to be expressed in various tissues and cells, including cancer cells. This makes it a potential candidate for use as a biomarker for cancer, as it may be expressed in the cores of tumors and can be used to monitor the effectiveness of various treatments.

Another potential use of LRRC52-AS1 as a biomarker is its ability to be regulated by various genetic and environmental factors, such as DNA methylation and gene expression. This may make it a potential candidate for use as a biomarker for various diseases, including cancer, where gene regulation is disrupted.

Conclusion

LRRC52-AS1 is a non-coding RNA molecule that has been shown to interact with LRRC52, a protein involved in various cellular processes. The potential interaction between LRRC52-AS1 and LRRC52 suggests that LRRC52-AS1 may play a role in regulating the activity of LRRC52. As a potential drug target or biomarker, LRRC52-AS1 is an attractive target for researchers to investigate and develop new treatments for various diseases.

Protein Name: LRRC52 Antisense RNA 1

The "LRRC52-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC52-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets